A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
Dihydroxyphenylalanine has been studied across 16 research domains including 🧠 Focus & Attention, 🌤️ Mood & Depression, 🧠 Neuroprotection, 🫘 Kidney, 🫁 Liver & Detox. The primary research focus is 🧠 Focus & Attention with 31% of studies addressing this area.
The following compounds share molecular targets with Dihydroxyphenylalanine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Dihydroxyphenylalanine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.